about
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced ageEfficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing ProgramGoing straight to the point: intra-BM injection of hematopoietic progenitors.Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.The Approach to Acute Lymphoblastic Leukemia in Older Patients: Conventional Treatments and Emerging Therapies.Prognostic significance of lymphoid enhancer-binding factor-1 expression in egyptian adult B-acute lymphocytic leukemia patients.Influence of age on outcome after allogeneic hematopoietic cell transplantation: a single center study in patients aged ⩾60.Canine acute leukaemia: 50 cases (1989-2014).Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.Bortezomib for the treatment of acute lymphoblastic leukemia
P2860
Q33838116-3BDA8B26-006F-4A7D-AF39-1DDA09D77382Q34543909-FEEE18E3-DD86-4036-9F78-0D50FD9F4234Q37715706-7B0EBCDA-9101-43D2-918A-E07FAC527478Q38226100-66E9EE60-17DA-4BBD-909E-0053F8224428Q38392656-07C3A77E-537C-4E77-B7E7-D073738F70C3Q38759431-824FF773-B2DA-4BB8-9BB9-F754A74884CFQ40921393-834A9DFA-3C50-4DDD-974A-CD03148305EDQ41564676-DBDED11D-8167-4130-9CCF-875DD21FA7E0Q44865468-61E6D424-9C21-4085-9DA4-A76CAB80E02FQ45349920-000818DF-739F-4DEB-9C0C-43579AD38478Q50201177-D3FBC390-3FF0-49C3-99CE-5781DE42EE4DQ51749546-3A25A6D3-6D2B-4E22-B885-3D80AF37E1C5Q57286691-598F7F33-BE74-4F9A-BDE7-80665D5BA1C9
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Optimal management of adults with ALL.
@en
Optimal management of adults with ALL.
@nl
type
label
Optimal management of adults with ALL.
@en
Optimal management of adults with ALL.
@nl
prefLabel
Optimal management of adults with ALL.
@en
Optimal management of adults with ALL.
@nl
P1476
Optimal management of adults with ALL.
@en
P2093
Jacob M Rowe
P304
P356
10.1111/J.1365-2141.2008.07513.X
P407
P577
2008-11-26T00:00:00Z